Kalorama Information

The recent announcement by U.S. drugstore giant CVS that its locations will phase out sales of tobacco products is jarring but should not be surprising, according to healthcare market research firm Kalorama Information.

Just five companies own the majority of the molecular diagnostics market as of this month, according to Kalorama Information. Kalorama thinks top-tier companies will continue to dominate due to their global reach and multi-segment participation.

Kalorama Information has published "Molecular Diagnostics Six Month Update," the latest look at this fast-growing IVD test segment.

New ‘smart’ infusion pump devices that can assist healthcare professionals in patient care through computer algorithms, warning features and connectivity are leading growth in the world market for infusion devices, finds Kalorama Information.

Kalorama Information announces the publication of "The Worldwide Market for Infusion Pumps." The report is Kalorama Information's most current and complete research into infusion pump devices used for patient treatment and nutrition.

Kalorama Information has published “IVD in Singapore and Malaysia,” a detailed look at the market for in vitro diagnostics in these important dual markets.

Faced with daunting reimbursement cuts and other challenges, the world market for clinical laboratory services grew just over one percent in the past five years, according to Kalorama Information.

Immunoassays conducted for the purpose of determining the presence of infectious disease in a patient lead the market for this important IVD test, both in size of market and in the rate of revenue growth, according to Kalorama Information.

"Clinical Laboratory Services" provides an in-depth market overview, a total market analysis, analysis by laboratory type, and by routine and specialty testing and a review of the latest trends driving growth.

At nearly $2 billion dollars, the veterinary diagnostics represent an ancillary but increasingly appealing course of market development for companies active in the $55 billion in vitro diagnostics (IVD) market, according to Kalorama Information.